Evidence map›Paper›PMID 42487139›Full record

ArticleGenome medicine2026

clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL.

Lukas Stoiber, Željko Antić, Stefano Rebellato, Grazia Fazio, Annika Rademacher, Lennart Lenk, Franco Locatelli, Adriana Balduzzi, Gunnar Cario, Carmelo Rizzari and 3 more

Abstract read
In one paragraph

Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lukas StoiberInstitute of Clinical Genetics and Genomic Medicine, University Hospital Würzburg, Würzburg, Germany.
Željko AntićInstitute of Clinical Genetics and Genomic Medicine, University Hospital Würzburg, Würzburg, Germany.
Stefano RebellatoTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Grazia FazioTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Annika RademacherDepartment of Pediatrics I, Pediatric Hematology and Oncology, ALL-BFM Study Group, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Lennart LenkDepartment of Pediatrics I, Pediatric Hematology and Oncology, ALL-BFM Study Group, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Franco LocatelliIRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Adriana BalduzziSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Gunnar CarioDepartment of Pediatrics I, Pediatric Hematology and Oncology, ALL-BFM Study Group, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Carmelo RizzariPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Giovanni CazzanigaTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Jiangyan YuInstitute of Clinical Genetics and Genomic Medicine, University Hospital Würzburg, Würzburg, Germany. Yu_J@ukw.de.
Anke Katharina BergmannInstitute of Clinical Genetics and Genomic Medicine, University Hospital Würzburg, Würzburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildhood T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with poor prognosis. Differently from B-cell precursor ALL, T-ALL lacks effective risk stratification strategies. A recent study has integrated whole genome and whole transcriptome data to define 17 distinct molecular subtypes with prognostic significance. However, clinical translation of this knowledge remains challenging due to the complexity of interpreting high-dimensional multi-omics-based data.

methodsHere, we present clinTALL, a deep learning based multi-task pipeline for pediatric T-ALL subtype classification and treatment outcome estimation. The model integrates multimodal input data and uses a neural network architecture to generate a shared latent embedding for jointly learned multi-task prediction. The competing risk-based model was used to predict event-specific outcomes. The model was trained on a publicly available multimodal dataset comprising clinical, genomic and transcriptomic features of 1309 pediatric T-ALL samples.

resultsWe observed that the transcriptomic-only model achieved superior single-modality results, with 92.2% accuracy for subtype prediction and a 65.9% concordance index (C-index) for event-free survival (EFS) in a cross-validation setup. Integrating all data modalities maintained high subtype classification accuracy (91.7%) and improved the overall concordance index for EFS estimation to 67.5%. The competing risk-based model enables accurate predictions of induction failure (C-index = 96.0%) and second malignant neoplasm (C-index = 62.1%). We validated molecular subtype predictions on an internal dataset of 120 pediatric T-ALL samples and obtained an accuracy of 81.8%. To facilitate the broad application of multi-omics based subtype prediction and treatment outcome inference, we provide clinTALL as a Docker based application, allowing for user friendly access to the tool.

conclusionsTogether, our machine learning-based framework allows for automated, accurate subtype classification and treatment outcome inference using multimodal input data, advancing precision risk stratification for pediatric T-ALL. The full source code of clinTALL is available on GitHub ( https://github.com/UKWgenommedizin/clinTALL ).

Indexed as

Machine LearningPrecursor T-Cell Lymphoblastic Leukemia-LymphomaChildChild, PreschoolClassification AlgorithmsGene Expression ProfilingHumansPrediction AlgorithmsPredictive Learning ModelsPrognosisTranscriptomeTreatment OutcomeCompeting riskMachine learningPediatric T-ALLSubtype classificationTreatment outcome prediction

Identifiers

PMID42487139
PMCPMC13393873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.